Abstract
Aim:
To investigate neuropeptide Y (NPY) expression in mouse hippocampus within early stages of kainic acid (KA) treatment and to understand its role in neuronal excitotoxicity.
Methods:
NPY expression in the hippocampus within early stages of KA intraperitoneal (ip) treatment was detected by immunohistochemistry (IHC) and in situ hybridization (ISH) methods. The role of NPY and Y5, Y2 receptors in excitotoxicity was analyzed by terminal deoxynucleotidyl transferase-mediated UTP nick end-labeling (TUNEL) assay.
Results:
Using IHC assay, in granule cell layer of the dentate gyrus (DG), NPY positive signals appeared 4 h after KA injection, reached the peak at 8 h and leveled off at 16 and 24 h. In CA3, no positive signal was found within the first 4 h after KA injection, but strong signal appeared at 16 and 24 h. No noticeable signal was detected in CA1 at all time points after KA injection. Using the ISH method, positive signals were detected at 4, 8, and 16 h in CA3, CA1, and hilus. In DG, much stronger ISH signals were detected at 4 h, but leveled off at 8 and 16 h. TUNEL analysis showed that intracerebroventricularly (icv) infusion of NPY and Y5, Y2 receptor agonists within 8 h after KA insult with proper dose could remarkably rescue pyramidal neurons in CA3 and CA1 from apoptosis.
Conclusion:
NPY is an important anti-epileptic agent. The preceding elevated expression of NPY in granule cell layer of DG after KA injection might partially explain its different excitotoxicity-induced apoptotic responses in comparison with the pyramidal neurons from CA3 and CA1 regions. NPY can not only reduce neuronal excitability but also prevent excitotoxicity-induced neuronal apoptosis in a time- and doserelated way by activation of Y5 and Y2 receptors.
Similar content being viewed by others
Article PDF
References
Choi DW . Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 623–34.
Choi DW . Excitotoxic cell death. J Neurobiol 1992; 23: 1261–76.
Lee JM, Zipfel GJ, Choi DW . The changing landscape of ischaemic brain injury mechanisms. Nature 1999; 399: A7–14.
Coyle JT, Puttfarcken P . Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689–95.
McNamara JO . Emerging insights into the genesis of epilepsy. Nature 1999; 399: A14–22.
Campocdhiaro P, Coyle J . Ontogenetic development of kainite neurotoxicity: correlates with glutamatergic innervation. Proc Natl Acad Sci USA 1978; 75: 2025–9.
Cook T, Crutcher K . Intrahippocampal injection of kainic acid produces significant pyramidal cell loss in neonatal rats. Neuroscience 1986; 18: 79–92.
Nadler J, Perry B, Cotman C . Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature 1978; 271: 676–7.
Ben-Ari Y . Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 1985; 14: 375–403.
Dudek F, Obenaus A, Schweitzer J, Wuarin J . Functional significance of hippocampal plasticity in epileptic brain: electrophysiological changes of the dentate granule cells associated with mossy fiber sprouting. Hippocampus 1994; 4: 259–65.
Nadler J . Kainic acid as a tool for the study of temporal lobe epilepsy. Life Sci 1981; 29: 2031–42.
Baraban SC, Hollopeter G, Erickson JC, Schwartzkroin PA, Palmiter RD . Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J Neurosci 1997; 17: 8927–36.
Zhao WJ, Ma YH, Fei J, Mei ZT, Guo LH . Increase in drug-induced seizure susceptibility of transgenic mice overexpressing GABA transporter-1. Acta Pharmacol Sin 2003; 24: 991–5.
Dong H, Csernansky CA, Goico B, Csernansky JG . Hippocampal neruogenesis follows kainic acid-induced apoptosis in neonatal rats. J Neurosci 2003; 23: 1742–9.
Colmers WF, Bleakman D . Effects of neuropeptide Y on the electrical properties of neurons. Trend Neurosci 1994; 17: 373–9.
Marsh DJ, Baraban SC, Hollopeter G, Palmiter RD . Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc Natl Acad Sci USA 1999; 96: 13518–23.
Vezzani A, Sperk G, Colmers W . Neuropeptide Y. Emerging evidence for a functional role in seizure modulation. Trends Neurosci 1999; 22: 25–33.
Woldbye D, Madsen TM, Larsen PJ, Mikkelsen JD, Bolwig TG . Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res 1996; 737: 162–8.
Wu Y, Zhang D, Lou D, Fan Y, Aronow D, Xu M, et al. c-fos regulates neuropeptide Y expression in mouse dentate gyrus. Neurosci Lett 2004; 363: 6–10.
Braissant O, Wahli W . A simplified in situ hybridization protocol using non-radioactively labeled probes to detect abundant and rare mRNAs on tissue sections. Biochemica 1998; 1: 10–6.
Marksteiner J, Sperk G, Maas D . Differential increases in brain levels of neuropeptide Y and vasoactive intestinal polypeptide after kainic acid-induced seizures in the rat. Naunyn Schmiedebergs Arch Pharmacol 1989; 339: 173–7.
Pitkänen A, Beal MF, Sirviö J, Swartz KJ, Männistö PT, Riekkinen PJ . Somatostatin, neuropeptide Y, GABA and cholinergic enzymes in brain of pentylenetetrazol-kindled rats. Neuropeptides 1989; 14: 197–207.
Tønder N, Kragh J, Finsen BR, Bolwig TG, Zimmer J . Kindling induces transient changes in neuronal expression of somatostatin, neuropeptide Y, and calbindin in adult rat hippocampus and fascia dentata. Epilepsia 1994; 35: 1299–308.
Gruber B, Greber S, Rupp E, Sperk G . Differential NPY mRNA expression in granule cells and interneurons of the rat dentate gyrus after kainic acid injection. Hippocampus 1994; 4: 474–82.
Kragh J, Tønder N, Finsen BR, Zimmer J, Bolwig TG . Repeated electroconvulsive shocks cause transient changes in rat hippocampal somatostatin and neuropeptide Y immunoreactivity and mRNA in situ hybridization signals. Exp Brain Res 1994; 98: 305–13.
Silva AP, Pinheiro PS, Carvalho AP, Carvalho CM, Jakobsen B, Zimmer J, et al. Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures. FASEB J 2003; 10: 122–31.
Guo H, Castro PA, Palmiter RD, Baraban SC . Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus. J Neurophysiol 2002; 87: 558–66.
Wahlestedt C, Reis DJ . Neuropeptide Y-related peptides and their receptors-are the receptors potential therapeutic drug targets? Annu Rev Pharmacol Toxicol 1993; 32: 309–52.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by a grant from the National Natural Science Foundation of China (No 30200241).
Rights and permissions
About this article
Cite this article
Wu, Yf., Li, Sb. Neuropeptide Y expression in mouse hippocampus and its role in neuronal excitotoxicity. Acta Pharmacol Sin 26, 63–68 (2005). https://doi.org/10.1111/j.1745-7254.2005.00011.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00011.x
Keywords
This article is cited by
-
Peptide YY: more than just an appetite regulator
Diabetologia (2014)
-
Experimental research on dynamic imbibition of fractured heavy oil reservoir under different temperatures
Journal of Petroleum Exploration and Production Technology (2014)
-
Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate
Cell Death & Disease (2013)